Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Which Sectors Lead Indices During Earnings Season examines which sectors typically drive index gains or losses, guiding allocation decisions.
26,374 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A bank ETF can be a reliable engine for a value-focused portfolio, capturing the cash-generating power of U.S. lender...
Abbott Laboratories moved higher after boosting its profit outlook and signaling strength across its diagnostics and ...
SpaceX has captured headlines with a powerful first day. This article explains what could drive spacex stock headed h...
When a high-profile ad flares into a public family moment, it isn’t just entertainment. It’s a lesson in brand risk, ...
A new covered-call ETF chasing a fat income stream uses the Russell 2000 as its base. This piece explains the mechani...
Geopolitical conflicts are upending the classic playbook for U.S. stocks. The S&P 500 has not followed the traditiona...
Investors have seen Broadcom swing from a rough start to a strong rally. This guide breaks down whether today is the ...
Bitcoin slid toward the $58,000 level as Strategy's STRC dropped to fresh lows and MSTR followed lower. This article ...
The cybersecurity talent gap is widening as AI skills grow faster than supply. A new market study shows hiring more s...
The Trump administration released a 2026 regulatory plan outlining 702 deregulatory actions across agencies, promisin...
In June, Netflix faced a sharp pullback as investors weighed slowing subscriber growth against rising content costs a...